FDA Investigator Pamela Y Lee
Pamela Y Lee has conducted inspections on 138 sites in 1 countries as of 09 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
138
Last Inspection Date:
09 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Pamela Y Lee:
Adriana Meza,
Aimee K Contreras,
Alexandra B Pitkin,
Ali Hernandez,
Aliza Chalapong Asawesna,
Barbara J Rincon,
Brandon R Boone,
Brian A Perkins,
Brian P Putz,
Bruce D Broidy,
Carla J Lundi,
Cathleen A Carr Sharpe,
Cathryn M Groehnert,
Celena Ngo,
Daniel J Simonsen,
Daniel Velasquez,
Davis,
Elizabeth M Dahl,
Erik D Sandvig,
Fe Q Reyes,
Francisco,
Frank P Bianco,
Geraldine M Peregrin,
Gordon Chu,
James P Stallings,
Janice Wai,
Jeanne A Young,
Jeannie Pradyanata,
Jennifer P Le,
Jessica B Clark,
Joey V Quitania,
John A Liu,
John C Su,
Jose O Caraballo Rivera,
Joseph C Francisco,
Judy C Nepsa,
Julia Ventura,
Katherine P Tran,
Kawshalya Pathiraja,
Keren Arkin,
Khang K Pham,
Lakecha N Lewis,
Leticia I Romero,
Lilly O Barton,
Lin Liu,
Ling Yu L Liu,
Lourdes M Countee,
Mabel M Lee,
Marco A Solorio,
Mark C Saale,
Mark I Nakano,
Matthew C Kristof,
Michael D Garcia,
Michael F Schuette,
Misty L Treece,
Miyo M Saito,
Myers,
Natalie J Ayoub,
Nicholas J Lahey,
Nicolas C Tolosa, III,
Ounchith J Phabmixay,
Pamela E Mokoko,
Patrick R Dimapindan,
Phal K Chhun,
Rachel E Hauser,
Ron K Berard,
Sabrina J Dethloff,
Sandra S Saniga,
Sean P Desbrow,
Sergio Chavez (NMI),
Sonya L Karsik, RAC,
Tamara L Alexander,
Tammy Vasquez Hancock,
Terrance P Nguyen,
Thao T Kwan,
Travell D Sawyer,
Trushani T Desai,
Wayne L Jefferson,
Wendelljoy G Manio
Pamela Y Lee's Documents
Publish Date | Document Type | Title |
---|---|---|
December, 2022 | FDA 483 | Sunright Corporation - Form 483, 2022-12-12 |
August, 2021 | EIR | APAC Chemical - EIR, 2021-08-13 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more